abstract |
The invention relates to the use of a compound that acts as an mGluR5 antagonist in the treatment, prevention and / or delay of the evolution of gastrointestinal tract disorders, urinary tract disorders and / or post-operative disorders and to the treatment, prevention and / or delay in the evolution of pain associated with these signs. |